Central and Peripheral Nervous System Changes as Markers of Disease Progression in Multiple Sclerosis
Sponsor: Region of Southern Denmark
This observational or N/A phase trial investigates Central Nervous System Lesion and Drug Effect and is currently completed. Region of Southern Denmark leads this study, which shows 13 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Nov 2021 — Dec 2021 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Jan 2021 — Nov 2021 [monthly]
Active Not Recruiting
▶ Show 8 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Aug 2020 — Nov 2020 [monthly]
Active Not Recruiting
-
May 2019 — Aug 2020 [monthly]
Active Not Recruiting
Status: Enrolling By Invitation → Active Not Recruiting
-
Jun 2018 — May 2019 [monthly]
Enrolling By Invitation
-
May 2018 — Jun 2018 [monthly]
Enrolling By Invitation
-
Apr 2018 — May 2018 [monthly]
Enrolling By Invitation
Phase: NA → None
-
Mar 2018 — Apr 2018 [monthly]
Enrolling By Invitation NA
Status: Active Not Recruiting → Enrolling By Invitation
-
Feb 2018 — Mar 2018 [monthly]
Active Not Recruiting NA
First recorded
Aug 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Region of Southern Denmark
- University of Southern Denmark
For direct contact, visit the study record on ClinicalTrials.gov .